• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Three endpoints of in vivo tumour radiobiology and their statistical estimation.体内肿瘤放射生物学的三个终点及其统计学估计。
Int J Radiat Biol. 2010 Feb;86(2):164-73. doi: 10.3109/09553000903419304.
2
Human tumour xenografts in radiotherapeutic research.
Radiother Oncol. 1985 Jan;3(1):35-46. doi: 10.1016/s0167-8140(85)80007-4.
3
Assessment of antitumor activity for tumor xenograft studies using exponential growth models.使用指数生长模型评估肿瘤异种移植研究中的抗肿瘤活性。
J Biopharm Stat. 2011 May;21(3):472-83. doi: 10.1080/10543406.2010.481802.
4
Tumour size: a factor influencing the isoeffect analysis of tumour response to combined modalities.肿瘤大小:影响肿瘤对联合治疗反应的等效效应分析的一个因素。
Br J Cancer Suppl. 1980 Apr;4:294-8.
5
The effect of radiation on tumour growth delay, cell survival and cure of the animal using a single tumour system.使用单一肿瘤系统研究辐射对动物肿瘤生长延迟、细胞存活及治愈情况的影响。
Br J Radiol. 1977 May;50(593):321-8. doi: 10.1259/0007-1285-50-593-321.
6
Relation of growth delay to cure for experimental tumour systems conforming to Poisson cure statistics.符合泊松治愈统计学的实验肿瘤系统中生长延迟与治愈的关系。
Br J Cancer. 1982 Jan;45(1):1-9. doi: 10.1038/bjc.1982.1.
7
Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours.分割放疗期间肿瘤细胞的再增殖:三种小鼠肿瘤中流式细胞术与放射生物学数据的相关性
Eur J Cancer. 1991;27(5):537-43. doi: 10.1016/0277-5379(91)90211-u.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
An historical survey of radiobiology and radiotherapy with fast neutrons.快中子放射生物学与放射治疗的历史综述。
Curr Top Radiat Res Q. 1976 Jan;11(1):1-86.
10
From imaging to dosimetry and biological effects.从成像到剂量测定及生物效应。
Q J Nucl Med Mol Imaging. 2011 Feb;55(1):44-56.

引用本文的文献

1
Improved drug-screening tests of candidate anti-cancer drugs in patient-derived xenografts through use of numerous measures of tumor growth determined in multiple independent laboratories.通过使用多个独立实验室确定的多种肿瘤生长测量方法,改进了在患者来源的异种移植模型中对候选抗癌药物的药物筛选测试。
PLoS One. 2025 Jun 18;20(6):e0324141. doi: 10.1371/journal.pone.0324141. eCollection 2025.
2
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells.DiPRO1 显著重编程肌肉和间充质癌细胞。
EMBO Mol Med. 2024 Aug;16(8):1840-1885. doi: 10.1038/s44321-024-00097-z. Epub 2024 Jul 15.
3
Boron Neutron Capture Therapy Enhanced by Boronate Ester Polymer Micelles: Synthesis, Stability, and Tumor Inhibition Studies.硼中子俘获治疗增强的硼酸酯酯聚合物胶束:合成、稳定性和肿瘤抑制研究。
Biomacromolecules. 2024 Jul 8;25(7):4215-4232. doi: 10.1021/acs.biomac.4c00298. Epub 2024 Jun 6.
4
Enhancement of Radiation Therapy through Blockade of the Immune Checkpoint, V-domain Ig Suppressor of T Cell Activation (VISTA), in Melanoma and Adenocarcinoma Murine Models.通过阻断免疫检查点、T 细胞激活的 V 结构域免疫球蛋白抑制剂(VISTA)增强黑色素瘤和腺癌的放射治疗。
Int J Mol Sci. 2023 Sep 6;24(18):13742. doi: 10.3390/ijms241813742.
5
GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models.抑制糖原合成酶激酶-3通过破坏中心体对胶质瘤干细胞具有细胞毒性,并增强原位模型中放射治疗的效果。
Cancers (Basel). 2021 Nov 25;13(23):5939. doi: 10.3390/cancers13235939.
6
Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting.卵巢癌患者来源异种移植(PDX)模型中重复测量肿瘤生长比较实验的统计分析。
Sci Rep. 2021 Apr 13;11(1):8076. doi: 10.1038/s41598-021-87470-x.
7
mNP hyperthermia and hypofractionated radiation activate similar immunogenetic and cytotoxic pathways.mNP 高热和低分割放射激活相似的免疫遗传和细胞毒性途径。
Int J Hyperthermia. 2020;37(1):929-937. doi: 10.1080/02656736.2020.1802070.
8
Nicotinamide riboside relieves paclitaxel-induced peripheral neuropathy and enhances suppression of tumor growth in tumor-bearing rats.烟酰胺核糖可缓解紫杉醇诱导的周围神经病变,并增强荷瘤大鼠的肿瘤生长抑制作用。
Pain. 2020 Oct;161(10):2364-2375. doi: 10.1097/j.pain.0000000000001924.
9
Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma.mTOR 激酶抑制剂联合 dasatinib 作为一种治疗前庭神经鞘瘤的新策略。
Sci Rep. 2020 Mar 6;10(1):4211. doi: 10.1038/s41598-020-60156-6.
10
Statistical determination of synergy based on Bliss definition of drugs independence.基于 Bliss 定义的药物独立性,通过统计学方法确定协同作用。
PLoS One. 2019 Nov 25;14(11):e0224137. doi: 10.1371/journal.pone.0224137. eCollection 2019.

本文引用的文献

1
Radiobiological basis for cancer therapy by total or half-body irradiation.全身或半身照射癌症治疗的放射生物学基础。
Nonlinearity Biol Toxicol Med. 2004 Oct;2(4):293-316. doi: 10.1080/15401420490900254.
2
Metastatic tumor doubling time is an independent predictor of intrapulmonary recurrence after pulmonary resection of solitary pulmonary metastasis from colorectal cancer.转移性肿瘤倍增时间是结直肠癌孤立性肺转移灶肺切除术后肺内复发的独立预测因素。
Dig Surg. 2008;25(3):220-5. doi: 10.1159/000140693. Epub 2008 Jun 23.
3
Growth laws in cancer: implications for radiotherapy.癌症生长规律:对放射治疗的启示。
Radiat Res. 2007 Sep;168(3):349-56. doi: 10.1667/RR0787.1.
4
The effects of Efaproxyn (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy-mediated inhibition of tumor growth in mice.依伐普酶(efaproxiral)对小鼠皮下RIF-1肿瘤氧合作用及放疗介导的肿瘤生长抑制增强作用的影响。
Radiat Res. 2007 Aug;168(2):218-25. doi: 10.1667/RR0962.1.
5
Endpoints for agents that slow tumor growth.减缓肿瘤生长的药物的终点指标。
Contemp Clin Trials. 2007 Jan;28(1):18-24. doi: 10.1016/j.cct.2006.05.011. Epub 2006 Jul 10.
6
Pretreatment photosensitizer dosimetry reduces variation in tumor response.预处理光敏剂剂量测定可减少肿瘤反应的差异。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1211-20. doi: 10.1016/j.ijrobp.2005.11.019.
7
Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer.
Jpn J Clin Oncol. 2004 Feb;34(2):82-5. doi: 10.1093/jjco/hyh011.
8
DYNAMICS OF TUMOR GROWTH.肿瘤生长动力学
Br J Cancer. 1964 Sep;13(3):490-502. doi: 10.1038/bjc.1964.55.
9
Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice.在携带小鼠肿瘤或人源异种移植瘤的小鼠中,将紫杉醇与缺氧选择性细胞毒素NLCQ-1联合使用的治疗优势。
Cancer Chemother Pharmacol. 2002 Dec;50(6):501-8. doi: 10.1007/s00280-002-0521-8. Epub 2002 Sep 26.
10
Nobody needs "relative tumour sizes" to compare tumour growth curves.没人需要“相对肿瘤大小”来比较肿瘤生长曲线。
Anticancer Res. 2001 Mar-Apr;21(2A):1181-2.

体内肿瘤放射生物学的三个终点及其统计学估计。

Three endpoints of in vivo tumour radiobiology and their statistical estimation.

机构信息

Section of Biostatistics and Epidemiology, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.

出版信息

Int J Radiat Biol. 2010 Feb;86(2):164-73. doi: 10.3109/09553000903419304.

DOI:10.3109/09553000903419304
PMID:20148701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2900851/
Abstract

PURPOSE

To review the existing endpoints of tumour growth delay assays in experimental radiobiology with an emphasis on their efficient estimation for statistically significant identification of the treatment effect. To mathematically define doubling time (DT), tumour-growth delay (TGD) and cancer-cell surviving fraction (SF) in vivo using exponential growth and regrowth models with tumour volume measurements obtained from animal experiments.

MATERIALS AND METHODS

A statistical model-based approach is used to define and efficiently estimate the three endpoints of tumour therapy in experimental cancer research.

RESULTS

The log scale is advocated for plotting the tumour volume data and the respective analysis. Therefore, the geometric mean should be used to display the mean tumour volume data, and the group comparison should be a t-test for the log volume to comply with the Gaussian-distribution assumption. The relationship between cancer-cell SF, TGD and rate of growth is rigorously established. The widespread formula for cell kill is corrected; it has been rigorously shown that TGD is the difference between DTs. The software for the tumour growth delay analysis based on the mixed modeling approach with a complete set of instructions and example can be found on the author's webpage.

CONCLUSIONS

The existing practice for TGD data analysis from animal experiments suffers from imprecision and large standard errors that yield low power and statistically insignificant treatment effect. This practice should be replaced with a model-based statistical analysis on the log scale.

摘要

目的

回顾实验放射生物学中肿瘤生长延迟测定的现有终点,并特别强调其对治疗效果的统计学显著性识别的有效估计。使用基于数学模型的方法,通过动物实验中获得的肿瘤体积测量值,在体内使用指数增长和再增长模型来定义倍增时间(DT)、肿瘤生长延迟(TGD)和癌细胞存活分数(SF)。

材料与方法

采用基于统计模型的方法来定义和有效地估计实验性癌症研究中肿瘤治疗的三个终点。

结果

建议在对数尺度上绘制肿瘤体积数据和相应的分析。因此,应使用几何平均值来显示平均肿瘤体积数据,并且为了符合正态分布假设,应使用对数体积进行组间比较 t 检验。严格建立了癌细胞 SF、TGD 和生长速率之间的关系。修正了广泛使用的细胞杀伤公式;已经严格证明 TGD 是 DT 的差异。基于混合建模方法的肿瘤生长延迟分析软件,带有完整的使用说明和示例,可以在作者的网页上找到。

结论

目前从动物实验中分析 TGD 数据的实践存在不精确性和较大的标准误差,导致功效低且统计学上无显著的治疗效果。这种做法应该被基于对数尺度的基于模型的统计分析所取代。